Dihydroisotanshinone I induces ferroptosis in Breast cancer cells by inhibiting GPX4, leading to depletion of intracellular glutathione and a sharp increase in GSSG(Ahmadi et al., 2020). Here, GPX4 is linked to breast cancer.